Design, synthesis, and biological evaluation of novel benzimidazolyl isoxazole derivatives as potential c-Myc G4 stabilizers to suppress c-Myc transcription and myeloma growth

Xiaoju Geng,Yan Zhang,Shihao Li,Linlin Liu,Ruosi Yao,Ling Liu,Jian Gao
DOI: https://doi.org/10.1016/j.molstruc.2022.134673
IF: 3.841
2022-01-01
Journal of Molecular Structure
Abstract:•Identification of benzimidazolyl isoxazole derivatives as new potent c-Myc G4 stabilizers.•Compound 3-(1-(2-(3,5-dimethylphenoxy)ethyl)-1H-benzo[d]imidazol-2-yl)-5-(4-fluorophenyl)isoxazole (EP12) exhibited better RPMI-8226 cell inhibition activity (IC50 = 6.16 µM).•Compound EP12 induced apoptosis and inhibited the expression of c-Myc mRNA and c-Myc protein at 5 µM..•Circular dichroism (CD) and molecular dynamics (MD) simulation studies indicated that compound EP12 could firmly stabilize c-Myc G4.
What problem does this paper attempt to address?